Magnetic resonance spectroscopy
This article was originally published in The Gray Sheet
Executive Summary
Agency for Healthcare Research & Quality will conduct a technology assessment of the procedure to distinguish cerebral tumors from abscesses, radiation necrosis or other infections and inflammations. CMS requested the assessment following an August request for a national coverage decision from the American College of Radiology. MRS is currently subject to a national non-coverage decision...